Abstract
The effect of two dosages of sarmazenil (RO 15-3505) on sleep propensity and performance was investigated in a double-blind, placebo-controlled paradigm. The design included three 24-h testing periods, separated by at least one 7-day rest period, commencing after 24-h of sleep deprivation. Twelve normal, healthy, adult males (mean age 27±2.8 years) were paid to participate. During the experimental periods, they came to the sleep laboratory at 2100 hours and spent the night awake under close supervision. At 0700 hours, a schedule of 7 min “attempting” sleep in bed, 13 min awake outside the bedroom, began. This schedule was maintained for 24 h. Repeated administrations of 1 mg and 2 mg sarmazenil significantly reduced the 24-h levels of total sleep. This was particularly evident during the period 0700–2300 hours. Sarmazenil also significantly improved reaction time and tended to increase the number of correct responses in the “categories search” task. Sarmazenil tended to improve reaction time in the “Stroop” test but this was significant only for the “easy” version of the test during the night.
Similar content being viewed by others
References
Darragh A, Ronacari G, Timm U, Zell M, Zumbrunnen R (1983) Pharmacokinetics of Ro 15-3505 during a tolerance study with increasing intravenous doses to healthy volunteers. Research Report, HLR on file
Fisk AD, Schnider W (1983) Category and word search: generalizing search principle to complex processing. J Exp Psychol [Learning Mem Cogn] 9:177–193
Gath I, Weidenfeld J, Collins GI, Hadad H (1984) Elecrophysiological aspects of benzodiazepine antagonists Ro 15-1788 and Ro 15-3505. Br J Clin Pharmacol 18:541–547
Gentil V, Gorenstein C, Camargo CHP, Singer JM (1989) Effects of Flunitrazepam on memory and their reversal by two antagonists. J Clin Psychopharmacol 9:191–197
Haefely W (1983) The biological basis of benzodiazepine actions. J Psychoact Drugs 15:19–39
Haefely W (1985) Pharmacology of benzodiazepine antagonists. Pharmacopsychiatry 18:163–166
Haefely W, Martin JR, Schoch P (1990) Novel anxiolytics acting as partial agonists at benzodiazepine receptors. Trends Pharmacol Sci 11:452–456
Halen CJ, Nutt DJ (1992) Effect of benzodiazepine receptor inverse agonists on locomotor activity and exploration in mice. Eur J Pharmacol 221:199–203
Lavie P (1986) Ultrashort sleep-waking schedule. III “gates” and “forbidden zones” for sleep. Electroencephalogr Clin Neurophysiol 63:414–425
Lavie P (1987) Ro 15-1788 decreases hypnotic effects of sleep deprivation. Life Sci 41:227–233
Lavie P (1989) Intrinsic effects of the benzodiazepine receptor antagonist RO 15-1788 in sleepy and alert subjects. Int J Neuro Sci 46:131–137
Lavie P, Segal S (1989) 24-h structure of sleepiness in morning and evening persons investigated by ultrashort sleep-wake cycle. Sleep 12:522–528
Lavie P, Weler B (1989) The timing of naps: relationship with post-nap sleepiness. Electroencephologr Clin Neurophysiol 72:218–224
Lavie P, Zvuloni A (1992) The 24-h sleep propensity function: experimental bases for somnotypology. Psychophysiology 29:566–575
Lavie P, Peled R, Wollman M, Zomer J, Tzischinsky O (1987) Agonistic-like effects of the benzodiazepine receptor antagonist RO 15-1788. Neuropsychobiology 17:72–76
Lorez HP, Martin JR, Keller H, Cumin R (1986) Effect of aniracetam and the benzodiazepine receptor partial inverse agonist RO 15-3505 on cerebral glucose utilization and cognitive function after lesioning of cholinergic forebrain nuclei in the rat. Drug Dev Res 14:359–362
Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Department of Health, Education and Welfare Public Health Service, Bethesda, Maryland US
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nave, R., Herer, P. & Lavie, P. The intrinsic effects of sarmazenil on sleep propensity and performance level of sleep-deprived subjects. Psychopharmacology 115, 366–370 (1994). https://doi.org/10.1007/BF02245078
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245078